Zepbound for Weight Loss
The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...
Smaller biotechs see new mechanisms of action as future of obesity treatments
Discover how small biotechs are innovating in the weight loss therapy market with new treatments targeting unique mechanisms ...
Yahoo Finance9d
Obesity market to reach $173.5bn by 2031
and the dual GLP-1R/GIPR agonist Mounjaro/Zepbound (tirzepatide), capable of promoting body weight loss of up to 25%. The ...
FiercePharma24d
Gearing up to challenge Lilly in obesity, Kailera picks Zepbound brand leader as new commercial chief
Not long after reporting phase 2 data for one of its obesity candidates that appeared to put it on par with Eli Lilly’s Zepbound, Kailera Therapeutics is preparing for an eventual market launch ...
Time29d
The Health Risks and Benefits of Weight-Loss Drugs
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing ...
Yahoo Finance25d
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
While Novo Nordisk's Ozempic is the most mainstream GLP-1 medication, Eli Lilly (NYSE: LLY) has two blockbuster weight loss drugs of its own: Mounjaro and Zepbound. Mounjaro and Zepbound are by ...